With the recognition of elevated succinate causing aberrant activation of CDK5, the anti-CDK5 inhibitor MRT3-007 was shown to suppress tumor growth in vitro as well as in xenograft mouse models with SDHB knockout (Gupta et al. 2022). The gene discussed is CDK5; the disease is neoplasm.